A Myriad of Changes - April 30, 2014
Wednesday, April 30, 2014 from 12:00 PM to 1:00 PM (EDT)
San Francisco, California
London, United Kingdom
"A Myriad of Changes: How the US Patent Office is making big changes to the examination of patent applications for personalized medicine and naturally occurring substances"
The US Patent and Trademark Office recently released formal guidelines that patent examiners are to follow when reviewing patent applications that cover diagnostic methods, including aspects of personalized medicine, and naturally occurring substances. These guidelines go beyond recent court rulings and expand the realm of what the patent office will consider "non-patentable subject matter". This seminar will introduce the audience to these changes, and provide suggestions for designing research that can generate protectable subject matter for those who work in the life sciences are aand have an entrepreneurial approach to their work.
John Lopinski is a partner with Hodgson Russ LLP, a Buffalo, New York based law firm. John holds a Ph.D. in the area of molecular biology and provides regular advice to universities and start-ups on developing IP strategies that encompass technology in the human and veterinary diagnostic and therapeutic areas.